Tumors in Space Investigates Microgravity’s Impact on Cancer Using Patient-Derived HUB Organoids
HUB Organoids official news RSS · Indexed industry source record · Source published: Thu Nov 30 2023 09:42:03 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
Utrecht, November 30, 2023 – HUB Organoids B.V. participates in the second Tumors in Space European Space Agency parabolic flight which investigates the effect of microgravity on gene expression to identify potential targets for drug discovery and precision medicine. The Tumors in Space program represents some of the most advanced cancer research ever conducted under […] The post Tumors in Space I
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.